Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Signal peptidase complex catalytic subunit SEC11C (SEC11C) is an enzyme found in the endoplasmic reticulum membrane that functions as a catalytic component of the signal peptidase complex (SPC)[1][3][5]. It enables serine-type endopeptidase activity and is directly involved in the crucial maturation step of secretory and membrane proteins by cleaving their N-terminal signal peptides as they are translocated into the lumen of the endoplasmic reticulum[1][3][4][5]. SEC11C recognizes and specifically cleaves the signal peptides containing hydrophobic alpha-helices, particularly those with h-regions shorter than 18–20 amino acids[3][5]. SEC11C, in coordination with the other SPC subunits, forms a unique transmembrane window to ensure substrate specificity and proper processing of newly synthesized proteins[1]. Dysregulation of SPC components, including SEC11C, has been associated with disease contexts such as lung adenocarcinoma, stressing its role in both fundamental cell biology and disease mechanisms[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Signal peptidase complex catalytic subunit SEC11C (SEC11C).